Category Archives: Top Market News

Leerink Partners Sticks to Its Hold Rating for Assembly Biosciences (ASMB)

Leerink Partners analyst Geoff Porges reiterated a Hold rating on Assembly Biosciences (ASMB – Research Report) on May 7 and set a price target of $7.00. The company’s shares closed last Thursday at $3.89, close to its 52-week low of

Analysts Have Conflicting Sentiments on These Technology Companies: L3Harris Technologies (NYSE: LHX), Huntington Ingalls (NYSE: HII) and Bombardier (Other OTC: BDRBF)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on L3Harris Technologies (LHX – Research Report), Huntington Ingalls (HII – Research Report) and Bombardier (BDRBF – Research Report). L3Harris Technologies (LHX) In a

Oppenheimer Remains a Buy on DermTech (DMTK)

In a report released today, Kevin DeGeeter from Oppenheimer maintained a Buy rating on DermTech (DMTK – Research Report), with a price target of $58.00. The company’s shares closed last Thursday at $29.14. According to TipRanks.com, DeGeeter is a 5-star

Mizuho Securities Thinks Avrobio’s Stock is Going to Recover

Mizuho Securities analyst Difei Yang maintained a Buy rating on Avrobio (AVRO – Research Report) today and set a price target of $28.00. The company’s shares closed last Thursday at $8.79, close to its 52-week low of $7.45. According to

Unity Software (U) Received its Third Buy in a Row

After Wedbush and Stifel Nicolaus gave Unity Software (NYSE: U) a Buy rating last month, the company received another Buy, this time from Oppenheimer. Analyst Brian Schwartz upgraded Unity Software to Buy today and set a price target of $103.00.

Analysts Conflicted on These Healthcare Names: Synlogic (NASDAQ: SYBX) and 89bio (NASDAQ: ETNB)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Synlogic (SYBX – Research Report) and 89bio (ETNB – Research Report). Synlogic (SYBX) In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Hold